Press Releases

IntegrateRNA Offers High-quality Oligonucleotide Conjuagted Services to Facilitate Diagnostic And Targeted Drug Delivery

Alfa Chemistry Materials Presents Carbon Nanotubes and Graphene with High Quality on its Website

The past decade has witnessed an increasing demand for novel materials such as carbon nanotubes and graphenes. To facilitate researcher’s purchase of novel material chemicals, Alfa Chemistry Materials, a material subsidiary of Alfa Chemistry, recently announces that both carbon nanotubes and graphenes with high quality are now presented as main featured products on its website.

Creative Biostructure Established Various Systems for Protein Expression in Pharmaceutical Field

Creative BioMart Biomarker Provides a Variety of Platforms for Imaging Biomarker Detection

Matexcel Provides Professional Product Analysis Services to Meet Evolving Demands

Lifeasible Provides a Full Range of Methods for Phytochemical Tests

Mission of Protheragen MedAI: to Seek Innovative Solutions for Drug Discovery and Life Science Research

Protheragen MedAI Releases Protein Structure Modeling Service

CD Formulation Is Able to Conduct API-Excipient Compatibility Analysis

WCG IRB Welcomes 2021 Class to International Fellows Program on Research Ethics

This annual program builds upon WCG IRB’s expertise and 50-year legacy of global service, protecting the safety of clinical trial participants, and preserving the scientific integrity of research protocols. The 2021 program offers virtual training globally, continuing efforts to improve IRB operations worldwide and educate the next generation of research leaders amid the COVID-19 pandemic.

eClinical Solutions to Showcase Data Strategies for Digital and Decentralized Trials at PHUSE, DIA and Other Key Industry Events

Mansfield, MA, May 27, 2021 — eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services that accelerate digital clinical initiatives, today announced that their thought leaders will be participating in a variety of industry events this spring to discuss the impact of data on future clinical trials. As data sources increase due to the demands for decentralized and patient-centric trials, sponsors and CROs are experiencing longer timelines for clinical data review, management and analyses.

eClinical Solutions Shares Business Strategies for Accelerated Clinical Trials Post Covid-19

eClinical thought leaders to discuss decentralized trials, digital transformation of clinical research and modernized clinical data infrastructures at upcoming industry events

Crucial Data Solutions and SISCAPA Assay Technologies Partner to Introduce a New Approach to Diagnostics and Remote Health Monitoring

Together, CDS and SAT are leveraging the latest mobile and wearable technologies to achieve remote, longitudinal tracking of biomarkers in clinical trials

BOC Sciences Provides Extensive Catalog of Isotope Labeled Products

TRIO Partners with eClinical Solutions to Power Digital Transformation in Clinical Trials for Cancer

Global clinical research organization selects eClinical’s elluminate clinical data platform to optimize trial efficiency and speed

ComputaBio Has Launched Molecular Dynamics Simulation Services for Drug R&D Projects

ComputaBio, a US supplier of professional computational biology services, has launched molecular dynamics simulation services for industrial and academic customers to expedite the process of drug design.

New Healthcare Industry Survey Reveals Majority of Healthcare Organizations Unprepared for ONC Cures Act Final Rule

Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities

Albumedix Ltd., a recognised global leader in recombinant human albumin specializing in the enablement of advanced therapies, has announced the completed expansion of the company’s commercial-scale manufacturing facility, alongside the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.

CD BioSciences Reveals Its Capabilities in Conducting Proof of Concept Research

CD BioSciences, a professional US provider of integrated solutions for clinical trials development, has revealed its capabilities of conducting Proof of Concept (PoC) studies and pivotal clinical research for drug development scientists in biological and pharmaceutical institutes and companies.

THREAD Launches New Telehealth Features Expanding Video and Audio Capture for Complex eCOA during Virtual Visits in Decentralized Clinical Trials

THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), today announced the launch of new telehealth features. Building on four years of conducting electronic clinical outcome assessments (eCOA) during telehealth virtual visits, the new features raise the bar in DCT telehealth functionality by adding several unique enhancements to the company’s industry-leading eCOA and telehealth virtual visit solution. New features allow clinical study stakeholders – including sponsors, caregivers, home health professionals and raters – to remotely and safely capture video and/or audio recordings in real time.